Active Ingredient(s): Icodextrin
FDA Approved: * December 20, 2002
Pharm Company: * BAXTER HLTHCARE
Category: Diabetes

Icodextrin (INN, USAN) is a colloid osmotic agent, derived from maltodextrin,[1] used in form of an aqueous solution for peritoneal dialysis under the trade name Extraneal,[2] and after gynecological laparoscopic surgery for the reduction of post-surgical adhesions (fibrous bands that form between tissues and organs) under the trade name Adept.[3] Contents 1 Chemistry 2 Mechanism of action 3 Pharmacokinetics 4 Contraindications 5 Adverse effec... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Extraneal Intraperitoneal Injection, Solution
NDC: 0941-0679
Baxter Healthcare Corporation